Executive Summary:
This notification, S.O. 4326(E), published on October 18, 2021, reconstitutes the Drugs Technical Advisory Board (DTAB). It supersedes notification S.O. 1929(E) dated May 15, 2018. The notification details the members of the reconstituted DTAB, in pursuance of section 5 of the Drugs and Cosmetics Act, 1940.
Key Points / Main Content:
* **DTAB Reconstitution:** The Central Government has reconstituted the Drugs Technical Advisory Board (DTAB).
* **Supersession:** This notification supersedes the previous notification S.O. 1929(E) dated May 15, 2018.
* **DTAB Members:**
* The board consists of a Chairman, a Member-Secretary and several other members, including ex-officio members, nominated members, and elected members.
* Members are appointed/nominated/elected under various sections of the Drugs and Cosmetics Act, 1940.
* The Director General of Health Services, New Delhi, serves as the Chairman.
* The Drugs Controller, India, New Delhi, serves as the Member-Secretary.
* **Effective Date:** The notification comes into force on the date of its publication in the Official Gazette.
Impact Analysis:
* **Drugs Technical Advisory Board (DTAB) Members:**
* Impact: Members are officially appointed, nominated, or elected to the reconstituted board, defining their roles and responsibilities.
* Action Required: Members should acknowledge their appointment and prepare to fulfill their duties on the board.
* **Ministry of Health and Family Welfare:**
* Impact: The Ministry is responsible for implementing and overseeing the reconstituted DTAB's operations.
* Action Required: Ensure the DTAB is functioning according to the Drugs and Cosmetics Act, 1940.
* **Drugs Controller, India:**
* Impact: Assumes the role of Member-Secretary of the Board.
* Action Required: Fulfill the responsibilities associated with the Member-Secretary position.
* **Government of India Press:**
* Impact: Responsible for uploading the notification.
* Action Required: Ensure correct uploading of the notification.
* **Controller of Publications, Delhi:**
* Impact: Responsible for publishing the notification.
* Action Required: Ensure timely and accurate publication of the notification.
Key Entities Referenced
Drugs and Cosmetics Act, 1940: An act of the Indian Parliament that regulates the import, manufacture, distribution and sale of drugs and cosmetics.
Ministry of Health and Family Welfare: A ministry in the Government of India responsible for health policy.
Drugs Technical Advisory Board (DTAB): A statutory body under the Drugs and Cosmetics Act, 1940 in India that advises the Central Government and State Governments on technical matters arising out of the Act.
New Delhi: The capital of India, where the notification was issued.
Director General of Health Services: A key position in the Ministry of Health and Family Welfare, Government of India.
Drugs Controller, India, New Delhi: Officer responsible for drug regulation in India.
Central Drugs Laboratory, Kolkata, West Bengal: A central drug testing laboratory in Kolkata.
Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh: A veterinary research institute located in Uttar Pradesh, India.
रजिस्ट्री स.ं डी.एल.- 33004/99 REGD. No. D. L.-33004/99
सी.जी.-डी.एल.-अ.-18102021-230506
xxxGIDHxxx
CG-DL-E-18102021-230506
xxxGIDExxx
असाधारण
EXTRAORDINARY
भाग II—खण् ड 3—उप-खण्ड (ii)
PART II—Section 3—Sub-section (ii)
प्राजधकार स ेप्रकाजित
PUBLISHED BY AUTHORITY
स.ं 3977] नई ददल्ली, सोमवार, अक्त बू र 18, 2021/आजव न 26, 1943
No. 3977] NEW DELHI, MONDAY, OCTOBER 18, 2021/ASVINA 26, 1943
स्ट्वास्ट््य एव ंपररवार कल्याण मत्रं ालय
(स्ट्वास्ट््य एव ंपररवार कल्याण जवभाग)
अजधसचू ना
नई ददल्ली, 18 अक् तूबर, 2021
का.अ. 4326(अ.).—औषजध और प्रसाधन सामग्री अजधजनयम, 1940 (1940 का 23) की धारा 5 की
उप-धारा (1) और (2) का अनपु ालन करते हुए तथा स्ट्वास्ट््य और पररवार कल्याण मंत्रालय में भारत सरकार की तारीख
15.05.2018 की अजधसूचना संख्या का.आ. 1929(अ) का अजधक्रमण करत े हुए केन्द्र सरकार एतद्द्वारा जनम्नजलजखत
सदस्ट्यों को िाजमल करत े हुए औषजध प्रौद्योजगकी सलाहकार बोडड का पुनगडठन करती ह,ै अथाडत्:—
क्र. स.ं सदस्ट्य का नाम/पदनाम बोड ड म ेंजस्ट्थजत औषजध और प्रसाधन सामग्री, 1940 जिसके तहत
जनयक्तु /मनोनीत/जनवाजड चत दकया गया
(1) (2) (3) (4)
1. स्ट्वास्ट््य सेवा महाजनदेिक, नई ददल्ली पदेन अध्यक्ष अजधजनयम की धारा 5 (2) (i) के तहत जनयुक्त दकया
गया
2. औषध जनयंत्रक, भारत, नई ददल्ली पदेन सदस्ट्य अजधजनयम की धारा 5 (2) (ii) के तहत जनयुक्त दकया
गया
3. जनदेिक, केन्द्रीय औषध प्रयोगिाला, पदेन सदस्ट्य अजधजनयम की धारा 5 (2) (iii) के तहत जनयक्तु
कोलकाता दकया गया
5988 GI/2021 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
4. जनदेिक, केन्द्रीय अनुसंधान संस्ट्थान, पदेन सदस्ट्य अजधजनयम की धारा 5 (2) (iv) के तहत जनयक्तु
कसौली दकया गया
5. जनदेिक, भारतीय पिु जचदकत्सा अनुसंधान पदेन सदस्ट्य अजधजनयम की धारा 5 (2) (v) के तहत जनयुक्त दकया
संस्ट्थान, इज्जतनगर, बरेली, उत्तर प्रदेि गया
6. अध्यक्ष, राष्ट्रीय आयुर्ववज्ञान आयोग पदेन सदस्ट्य अजधजनयम की धारा 5 (2) (vi) के तहत जनयक्तु
दकया गया
7. अध्यक्ष, भारतीय फामेसी पररषद पदेन सदस्ट्य अजधजनयम की धारा 5 (2) (vii) के तहत जनयुक्त
दकया गया
8. जनदेिक, केन्द्रीय औषध अनुसधं ान संस्ट्थान, पदेन सदस्ट्य अजधजनयम की धारा 5 (2) (viii) के तहत जनयक्तु
लखनऊ
9. आयुक्त, एफडीए, मध्य प्रदेि सदस्ट्य अजधजनयम की धारा 5 (2) (ix) के तहत मनोनीत
10. आयुक्त, एफडीसीए, गुिरात सदस्ट्य अजधजनयम की धारा 5 (2) (ix) के तहत मनोनीत
11. प्रो. (डॉ.) िैलन्द्े र सराफ, यूजनवर्वसटी सदस्ट्य अजधजनयम की धारा 5 (2) (x) के तहत चुना गया
इंस्ट्टीटयूट ऑफ़ फामेसी, प.ं रजविंकर
िुक्ला यूजनवर्वसटी
12. डॉ. जविय ओज़ा, सदस्ट्य (पीिीएमईबी), सदस्ट्य अजधजनयम की धारा 5 (2) (xi) के तहत चुन ेगए
एनएमसी
13. श्री सुधीर मेहता, अध्यक्ष, टोरेंट सदस्ट्य अजधजनयम की धारा 5 (2) (xii) के तहत मनोनीत
फामाडस्ट्युरटकल्स
14. डॉ. िेररन िोस चेररयन, साइंरटस्ट्ट डी, सदस्ट्य अजधजनयम की धारा 5 (2) (xiii) के तहत चुन ेगए
बुजनयादी जचदकत्सा जवज्ञान जवभाग,
आईसीएमआर
15. डॉ. ि ेए ियालाल, राजष्ट्रय अध्यक्ष, इंजडयन सदस्ट्य अजधजनयम की धारा 5 (2) (xiv) के तहत चुन े गए
मेजडकल एसोजसएिन
16. डॉ. टी.वी. नारायणा, अध्यक्ष, इंजडयन सदस्ट्य अजधजनयम की धारा 5 (2) (xv) के तहत चुना गया
फामाडस्ट्युरटकल एसोजसएिन
17. सरकारी जवश्लेषक, ड्रग्स टेस्स्ट्टग लेबोरेटरी, सदस्ट्य अजधजनयम की धारा 5 (2) (xvi) के तहत मनोनीत
बेंगलरुु , कनाडटक
18. सरकारी जवश्लेषक, खाद्य एवं औषजध सदस्ट्य अजधजनयम की धारा 5 (2) (xvi) के तहत मनोनीत
प्रयोगिाला, वडोदरा, गुिरात
2. औषजध महाजनयंत्रक, भारत, इस बोडड के सदस्ट्य-सजचव होंगे।
3. यह अजधसूचना सरकारी रािपत्र में इसके प्रकािन की तारीख से लाग ूहो िाएगी।
[फा. सं. एक्स-19012/2/2009-डीएफक्यूसी (पाट)ड ]
डॉ. मनदीप के. भण्डारी, संयुक्त सजचव[भाग II—खण् ड 3(ii)] भारत का रािपत्र : असाधारण 3
MINISTRY OF HEALTH AND FAMILY WELFARE
(Department of Health and Family Welfare)
NOTIFICATION
New Delhi, the 18th October, 2021
S.O. 4326(E).—In pursuance of sub-sections (1) and (2) of section 5 of the Drugs and Cosmetics
Act, 1940 (23 of 1940) and in supersession of the notification of the Government of India in the Ministry of
Health & Family Welfare, No. S.O. 1929(E) dated the 15th May, 2018, the Central Government hereby
reconstitutes the Drugs Technical Advisory Board (DTAB) consisting of the following members,
namely:—
Name/Official Designation of the Status in Section of the Drugs and Cosmetics Act,
Member 1940 under which appointed/nominated/
S. N. DTAB
elected
(1) (2) (3) (4)
1. The Director General of Health Chairman Appointed under Section 5(2)(i) of the Act
Services, New Delhi ex-officio
2. The Drugs Controller, India, New Member Appointed under Section 5(2)(ii) of the Act
Delhi ex-officio
3. The Director, Central Drugs Member Appointed under Section 5(2)(iii) of the Act
Laboratory, Kolkata ex-officio
4. The Director, Central Research Member Appointed under Section 5(2)(iv) of the Act
Institute, Kasauli ex-officio
5. The Director, Indian Veterinary Member Appointed under Section 5(2)(v) of the Act
Research Institute, Izatnagar, ex-officio
Bareilly, U.P.
6. The Chairman, National Medical Member Appointed under Section 5(2)(vi) of the Act
Commission, India ex-officio
7. The President, Pharmacy Council of Member Appointed under Section 5(2)(vii) of the Act
India ex-officio
8. The Director, Central Drug Research Member Appointed under Section 5(2)(viii) of the Act
Institute, Lucknow ex-officio
9. Commissioner, FDA, Madhya Member Nominated under Section 5(2)(ix) of the Act
Pradesh
10. Commissioner, FDCA, Gujarat Member Nominated under Section 5(2)(ix) of the Act
11. Prof. (Dr.) Shailendra Saraf, Member Elected under Section 5(2)(x) of the Act
University Institute of Pharmacy, Pt.
Ravishankar Shukla University
12. Dr. Vijay Oza, Member (PGMEB), Member Elected under Section 5(2)(xi) of the Act
NMC
13. Shri Sudhir Mehta, Chairman, Member Nominated under Section 5(2)(xii) of the Act
Torrent Pharmaceuticals
14. Dr. Jerin Jose Cherian, Scientist D, Member Elected under Section 5(2)(xiii) of the Act
Division of Basic Medical Sciences,
ICMR
15. Dr. J.A. Jayalal, National President, Member Elected under Section 5(2)(xiv) of the Act
Indian Medical Association4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
16. Dr. T.V. Narayana, President, Indian Member Elected under Section 5(2)(xv) of the Act
Pharmaceutical Association
17. Government Analyst, Drugs Testing Member Nominated under Section 5(2)(xvi) of the Act
Laboratory, Bengaluru, Karnataka
18. Government Analyst, Food & Drugs Member Nominated under Section 5(2)(xvi) of the Act
Laboratory, Vadodara, Gujarat
2. The Drugs Controller (India) shall be the Member-Secretary of the Board.
3. This Notification shall come into force on the date of its publication in the Official Gazette.
[F. No. X-19012/2/2009-DFQC(Pt)]
Dr. MANDEEP K BHANDARI, Jt. Secy.
Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064
and Published by the Controller of Publications, Delhi-110054.